Status:

COMPLETED

Comparison of the Effectiveness of Local Ozone Injection and Dextrose Prolotherapy Injection in Chronic Plantar Fasciitis

Lead Sponsor:

Ahi Evran University Education and Research Hospital

Conditions:

Plantar Fascitis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The aim of our study was to investigate the effect of local ozone injection and dextrose prolotherapy applications on pain and foot functions to compare the efficacy and to evaluate the thickness of t...

Detailed Description

In this study, 60 plantar fasciitis patients aged between 18 and 75 years admitted to Kırşehir Ahi Evran University Training and Research Hospital were examined. Plantar fasciitis (PF) is a common cau...

Eligibility Criteria

Inclusion

  • 18-75 years old, both sexes
  • Pain in the plantar medial calcaneal tubercle on palpation for more than 3 months
  • Accepting to participate in the study
  • Heel pain, especially in the first few steps in the morning, increasing with loading during the day
  • Patients with an initial VAS assessment of 4 or more on a 10 cm scale

Exclusion

  • Hyperthyroidism
  • Glucose6 phosphate dehydrogenase deficiency
  • Ozone allergy
  • Acute metabolic disease comorbidity (acute MI, acute hyperglycaemia, diabetic ketoacidosis, acute cerebrovascular disease etc.)
  • Pregnancy and breastfeeding
  • Malignite
  • Epilepsy
  • Tipl, having a history of type 2 diabetes
  • History of inflammatory rheumatic disease
  • History of bleeding disorders
  • Use of anticoagulants other than aspirin
  • Local corticosteroid injection into the plantar fascia within the last 3 months to have a story
  • ESWT treatment of the plantar fascia in the last 3 months
  • To have received physiotherapy to the foot, ankle area within the last 3 months
  • History of foot and ankle surgery
  • Active infection at the application site (cellulitis, erysipelas, etc.)
  • Allergy to dextrose
  • History of peripheral neuropathy
  • SI radiculopathy

Key Trial Info

Start Date :

August 5 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05984121

Start Date

August 5 2023

End Date

March 15 2024

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kırşehir Ahi Evran Üniversitesi

Kırşehir, Kırşehir, Turkey (Türkiye), 40100